NEW YORK ( TheStreet) -- The following 10 global pharmaceutical stocks will likely benefit from an expected 5%-7% growth in global pharmaceutical markets in 2011 to $880 billion, according to IMS Health.Analysts expect these 10 stocks to outperform their peers and broader markets, based on the upside implied from their respective 12-month price targets. These stocks have an upside potential of 28%-70% with a mean upside value of around 40% and average buy ratings of 69%.
10 Pharma Stocks With Upside
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.